Brookfield Real Assets Income Fund Inc.

12.76

-0.0500-0.39%

Pre-market: 12.760.00000.00%08:12 EDT

Volume:146.05K

Turnover:1.87M

Market Cap:705.05M

PE:10.81

High:12.85

Open:12.83

Low:12.75

Close:12.81

52wk High:13.59

52wk Low:11.87

Shares:55.25M

Float Shares:55.25M

Volume Ratio:0.97

T/O Rate:0.26%

Dividend:1.42

Dividend Rate:11.09%

EPS(TTM):1.18

ROE:--

ROA:--

PB:0.88

PE(LYR):- -

Loading ...

Overview Company News Filings

Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity

GlobeNewswire

·

Sep 23, 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RA/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RA\",,,,,undefined,":{"symbol":"RA","market":"US","secType":"STK","nameCN":"Brookfield Real Assets Income Fund Inc.","latestPrice":12.76,"timestamp":1773864000000,"preClose":12.81,"halted":0,"volume":146054,"hourTrading":{"tag":"盘前","latestPrice":12.76,"preClose":12.76,"latestTime":"08:12 EDT","volume":10,"amount":127.6,"timestamp":1773922364624,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0039032006245121554,"floatShares":55245934,"shares":55254696,"eps":1.18,"marketStatus":"Pre-Mkt","change":-0.05,"latestTime":"03-19 09:01:33 EDT","open":12.83,"high":12.85,"low":12.75,"amount":1869847.5717600002,"amplitude":0.007806,"askPrice":12.82,"askSize":256,"bidPrice":11.55,"bidSize":100,"shortable":3,"etf":0,"ttmEps":1.18,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773927000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":12.76,"dividendRate":0.110933,"preHourTrading":{"tag":"盘前","latestPrice":12.76,"preClose":12.76,"latestTime":"08:12 EDT","volume":10,"amount":127.6,"timestamp":1773922364624,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":12.92,"preClose":12.76,"latestTime":"19:20 EDT","volume":129,"amount":1663.38,"timestamp":1773876044202,"change":0.16,"changeRate":0.012539,"amplitude":0.012539},"volumeRatio":0.9716076147468429},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RA\",,,,,undefined,":{"symbol":"RA","floatShares":55245934,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9716076147468429,"shares":55254696,"dividePrice":1.4155,"high":12.85,"amplitude":0.007806,"preClose":12.81,"low":12.75,"week52Low":11.87,"pbRate":"0.88","week52High":13.59,"institutionHeld":0,"latestPrice":12.76,"committee":-0.438202,"eps":1.18,"divideRate":0.110933,"volume":146054,"delay":0,"ttmEps":1.18,"open":12.83,"prevYearClose":12.96,"prevWeekClose":12.74,"prevMonthClose":13.46,"prevQuarterClose":12.96,"fiveDayClose":12.91,"twentyDayClose":13.59,"sixtyDayClose":12.85},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RA\",params:#limit:5,,,undefined,":[{"date":"2026-03-12","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-12","defaultRemindTime":1773322200000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-26","payableDate":"2026-03-12","currency":"USD","dateTimestamp":1773288000000,"payDate":"2026-03-26"},{"date":"2026-02-05","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-05","defaultRemindTime":1770301800000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-19","payableDate":"2026-02-05","currency":"USD","dateTimestamp":1770267600000,"payDate":"2026-02-19"},{"date":"2026-01-08","symbol":"RA","amount":0.118,"announcedDate":"2025-12-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-08","defaultRemindTime":1767882600000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-22","payableDate":"2026-01-08","currency":"USD","dateTimestamp":1767848400000,"payDate":"2026-01-22"},{"date":"2025-12-11","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-11","defaultRemindTime":1765463400000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-11","currency":"USD","dateTimestamp":1765429200000,"payDate":"2025-12-26"},{"date":"2025-11-13","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-13","defaultRemindTime":1763044200000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-28","payableDate":"2025-11-13","currency":"USD","dateTimestamp":1763010000000,"payDate":"2025-11-28"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RA\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-13","recordDate":"2016-12-15","paymentDate":"2016-12-22","value":0.199,"currency":"USD"},{"executeDate":"2017-03-14","recordDate":"2017-03-16","paymentDate":"2017-03-23","value":0.199,"currency":"USD"},{"executeDate":"2017-04-18","recordDate":"2017-04-20","paymentDate":"2017-04-27","value":0.199,"currency":"USD"},{"executeDate":"2017-05-16","recordDate":"2017-05-18","paymentDate":"2017-05-25","value":0.199,"currency":"USD"},{"executeDate":"2017-06-13","recordDate":"2017-06-15","paymentDate":"2017-06-22","value":0.199,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RA\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2569761790","title":"Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2569761790","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569761790?lang=en_us&edition=fundamental","pubTime":"2025-09-23 20:30","pubTimestamp":1758630600,"startTime":"0","endTime":"0","summary":"MIAMI, FL, Sept.  23, 2025  (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometaboli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/23/3154675/11676/en/Veru-Announces-Successful-FDA-Meeting-Providing-Regulatory-Clarity-for-Enobosarm-for-Muscle-Preservation-in-Combination-with-GLP-1-RA-for-Greater-Weight-Loss-in-the-Treatment-of-Ob.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RA","BK4590","BK4183","GLP","VERU","BK4557","BK4007","BK4584","BK4144"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":41,"code":"91000000","status":"200"}]}}